PC PAL is pleased to announce that GrowthXP Neo, our specialist solution for visualising neonatal data, will be updated to incorporate the new national Swedish guidelines for neonatal hyperbilirubinemia, published in 2025 (https://neo.barnlakarforeningen.se/riktlinjer-vardprogram/metabolism-hematologi/metabolism-hematologi/ )
Hyperbilirubinemia, the cause of newborn jaundice, affects more than half of all babies. While often harmless, in some cases bilirubin levels may rise rapidly and could lead to severe complications, including kernicterus and long-term neurological damage. Careful clinical monitoring of bilirubin levels, as performed by healthcare providers, is therefore critical, particularly for preterm infants who are at greater risk.
The updated Swedish guidelines introduce important advances, including:
- Separate bilirubin curves for each gestational week (22–40 weeks), improving precision in assessing treatment thresholds.
- Revised phototherapy limits, providing greater safety margins for babies born at 37–38 weeks while reducing unnecessary treatment in older term infants.
- Clearer guidance on monitoring intervals and treatment escalation, supporting more consistent practice across neonatal teams.
- Integration with digital decision support tools, aligning with international standards (AAP and NICE) and enabling more equitable care delivery.
By embedding these guidelines directly into GrowthXP Neo, neonatologists will be able to visualise bilirubin data against the most up-to-date reference standards, supporting faster, evidence-based decisions for their patients.
This development underscores PC PAL’s role at the forefront of medical informatics. By continuously integrating new scientific knowledge and national recommendations, we ensure that our products deliver clinically relevant, and future-proof digital support. As with all PC PAL installations, local growth references are applied to ensure accuracy in each healthcare setting.
With this enhancement, GrowthXP Neo further strengthens its position as a trusted tool for neonatal specialists and a partner to healthcare software providers committed to innovation in paediatric care.
